Active pharmaceutical ingredients

and CDMO

GMP API & CDMO Made in Germany


We are Arevipharma


We are a privately owned medium-sized company. This gives us the freedom to react flexibly and individually to our customers’ requests and inquiries.


With our active ingredients, we make a decisive contribution to the health of millions of people around the world – which is why we place the highest demands on the quality of our products and our actions.


Experienced teams of chemists, engineers and project managers guarantee first-class customer support at the highest standards. Our decades of expertise allow us to produce active ingredients of numerous volume and substance classes.


We serve customers in all major global pharmaceutical markets and thus offer comprehensive expertise for all technical and regulatory requirements of our partners.


The protection of our employees, the environment and the safety of our production facilities is our top priority. As a German manufacturer, we ensure the highest standards for our global customers and partners.

Your reliable partner

From grams to tons

Arevipharma is a medium-sized manufacturer of active pharmaceutical ingredients and contract manufacturer for pharmaceutical customers around the world. In our production facilities in Radebeul, we develop, produce and store APIs of numerous volume and safety classes, specializing in the complex and demanding handling of narcotics. Our nearly 150-year corporate history as a synthetic API manufacturing facility is the DNA of our value creation. As a fully integrated site, we have the ability to respond quickly, flexibly, comprehensively, sustainably and reliably to the requests and requirements of our global customers and business partners.



Experienced chemists and project managers develop and optimise synthesis processes to the latest scientific standards, tailor-made for our production facilities



We have five production facilities for the cGMP manufacture of all API volumes in the range of a few grams to many tonnes



Numerous storage options for many temperature ranges and substance classes are available at the Radebeul site.



We develop, validate and transfer all required analytical methods. In our daily routine, we ensure that all starting materials, intermediates, and final products are tested against their specifications.



We are committed to the quality policy. Our management is committed to strict compliance with all cGMP requirements. We ensure that all processes are carried out in accordance with regulatory requirements and the needs of our customers.


Regulatory Affairs

We hold over 150 authorisations for our active substances and are represented with them on all continents and in the largest global pharmaceutical markets.



A team of sales people, project managers, sales operations and supply chain specialists serve global small, medium and big pharma customers to underline our outstanding quality with the best customer service.

Learn more

Active pharmaceutical ingredients since 1874

Our history

Arevipharma’s roots date back to 1874. The “Salicylic Acid Factory Dr. F. von Heyden” produced the world’s first active ingredient manufactured by a technical process.

Locally active

Our commitment

Beats against cancer, food bank Radebeul and our own bees. Our region is close to our hearts!


Acquistion of Arevipharma by Yonsung Group

The Active Pharmaceutical Ingredient (API) business of Arevipharma at their Radebeul site will be extended by innovation and investments, with strategic focus on outstanding quality, customer service as well as secured supplies and supply chains Radebeul, Germany – by 1st of January 2021 the acquisition of Arevipharma by Yonsung Group…
Successful FDA Inspection

Successful FDA Inspection

Dear Stakeholders, This is to inform you that our site in Radebeul, Germany, was inspected by the US Food and Drug Administration (US-FDA) from 25. – 29. April 2016. The audit has covered quality systems, equipment and facilities, materials, production, packaging, labeling and laboratory controls. We are proud to announce…

We are happy to advise you

We are looking forward to your inquiry
regarding our active ingredient portfolio or your CDMO project.